This year marks 30 years since the world’s first #CordBlood transplant in France by Dr Eliane Gluckman. To date there's been over 35,000 #CordBloodTransplants worldwide! #WCBD18#WorldCordBloodDay Help us continue vital #StemCell research by donating today https://t.co/3ggPkpR5Dr
Odds of using cord blood: Parents are most likely to need their baby's cord blood to get therapy for cerebral palsy or autism. The "80 diseases" treated by transplant are all rare. https://t.co/i0H1cAHwPY
Thank you @EdisonHSTech for preparing my daughter for a career in graphic design. She will attend BFA program at @lesley_u with both merit scholarship and portfolio scholarship.
On cell therapy pricing, Choulika $CLLS says there's one thing "no one talks about": big pharma minimum floor is 85% gross margin. Anything less and a drug is not profitable #Jefferies17
Lonza Pharma&Biotech’s Uwe Gottschalk, Chief Scientific Officer, at #pharmaintegrates: “We need a paradigm shift in Pharma manufacturing if personalized medicine is to become a reality for patients.”
2017 #MetcalfPrize winner Jessica Mar @AIBNatUQ is analysing how we and our stem cells age. She can also tell you why single cell biology is more like a fruit salad than a smoothie... and why that's important https://t.co/xPHC1lfkAY
Clinical trials with cord blood & other perinatal cells: Statistics for the decade 2005-2015 published OPEN ACCESS. #WorldCordBloodDay https://t.co/kpLMgOy8MP
For the cord blood banking industry, this new clinical trial could be the rising tide that floats all boats: EXPANDED ACCESS for children with Autism and Cerebral Palsy. https://t.co/E3UBT7wkRG